Vial, a global tech-driven contract research organization (CRO), has announced a strategic partnership with Mason America Inc., a provider of mobile infrastructure for smart hardware products. This collaboration will see Mason providing Vial with hardware as a service for clinical sites, enabling remote management of devices for eSource on a global scale. The partnership aims to accelerate the development of new therapies and devices for sponsors and patients by leveraging cutting-edge technology and hardware infrastructure.
Simon Burns, CEO and Co-Founder of Vial, emphasizes that this alliance will bring innovation and efficiency to clinical trials by enabling direct data capture and ensuring seamless shipping, setup, and user experiences at clinical sites. Vial’s technology platform, which combines eSource, EDC, and ePRO into one connected system, is designed to streamline site processes and deliver a consumer-grade experience and next-generation performance to eClinical software.
Jim Xiao, President of Mason, expresses enthusiasm about the venture, highlighting the potential for transformative changes in the healthcare and biotech sectors through this collaboration. The partnership has already seen significant results, with Mason’s tablets being successfully deployed to clinical trial sites across the United States, enhancing data collection and providing a seamless eSource experience for healthcare professionals and patients.